Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026)
Tilray Brands (TLRY) reported Non-Current Deferred Tax Liability of $7.9 million for Q1 2026, up 40.11% quarter-over-quarter from $5.6 million in Q4 2025.
Tilray Brands (TLRY) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Tilray Brands has reported Non-Current Deferred Tax Liability for 9 years, with the latest figure at $7.9 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Deferred Tax Liability changed N/A year-over-year to $7.9 million; the trailing twelve-month figure through Feb 2026 stood at $7.9 million (changed N/A YoY), and the FY2025 full-year result was $3.7 million, down 98.47% from the prior year.
- Non-Current Deferred Tax Liability for Q1 2026 stood at $7.9 million, up from $5.6 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $244.5 million in Q2 2024, with the low at $1.9 million in Q3 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $134.8 million across 5 years, with a median of $165.4 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 46.09% — and 2025, when it sank 98.57%.
- Tilray Brands' Non-Current Deferred Tax Liability stood at $180.1 million in 2022, then decreased by 7.58% to $166.5 million in 2023, then slipped by 24.32% to $126.0 million in 2024, then sank by 95.54% to $5.6 million in 2025, then jumped by 40.11% to $7.9 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $7.9 million (Q1 2026), $5.6 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 7.88 Mn |
| Feb 28, 2026 | 7.88 Mn |
| Nov 30, 2025 | 5.62 Mn |
| Nov 30, 2025 | 5.62 Mn |
| Aug 31, 2025 | 1.94 Mn |
| Aug 31, 2025 | 1.94 Mn |
| May 31, 2025 | 3.75 Mn |
| May 31, 2025 | 3.75 Mn |
| Nov 30, 2024 | 125.98 Mn |
| Nov 30, 2024 | 125.98 Mn |
| Aug 31, 2024 | 136.23 Mn |
| Aug 31, 2024 | 136.23 Mn |
| May 31, 2024 | 244.50 Mn |
| May 31, 2024 | 244.50 Mn |
| Feb 29, 2024 | 161.04 Mn |
| Feb 29, 2024 | 161.04 Mn |
| Nov 30, 2023 | 166.45 Mn |
| Nov 30, 2023 | 166.45 Mn |
| Aug 31, 2023 | 169.63 Mn |
| Aug 31, 2023 | 169.63 Mn |